What is Anika Therapeutics's change in AP?

Anika Therapeutics (ANIK) reported change in AP of $745K in Q1 2026.

How has Anika Therapeutics's change in AP changed year-over-year?

Anika Therapeutics's change in AP increased by 1485.1% year-over-year, from $47K to $745K.

What is the long-term trend for Anika Therapeutics's change in AP?

Over 3 years (2021 to 2025), Anika Therapeutics's change in AP has grown at a -66.3% compound annual growth rate (CAGR), from -$1.1M to $42K.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Anika Therapeutics ANIK Change in AP

Change in AP at other companies

VericelVCEL

$2.59M+570%

Zimmer Biomet HoldingsZBH

-$183M-403%

Pacira BioSciences, Inc.PCRX

-$936K-138%

BioventusBVS

-$15.37M+60.7%

Xtant Medical HoldingsXTNT

$1.64M+284%

Globus MedicalGMED

$5.08M+665%

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's change in AP?: Anika Therapeutics (ANIK) reported change in AP of $745K in Q1 2026.
How has Anika Therapeutics's change in AP changed year-over-year?: Anika Therapeutics's change in AP increased by 1485.1% year-over-year, from $47K to $745K.
What is the long-term trend for Anika Therapeutics's change in AP?: Over 3 years (2021 to 2025), Anika Therapeutics's change in AP has grown at a -66.3% compound annual growth rate (CAGR), from -$1.1M to $42K.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.